Search Results - "Cowan, Graeme J. M."
-
1
A novel malaria vaccine candidate antigen expressed in Tetrahymena thermophila
Published in PloS one (29-01-2014)“…Development of effective malaria vaccines is hampered by the problem of producing correctly folded Plasmodium proteins for use as vaccine components. We have…”
Get full text
Journal Article -
2
A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response
Published in PloS one (26-10-2011)“…Polymorphic parasite antigens are known targets of protective immunity to malaria, but this antigenic variation poses challenges to vaccine development. A…”
Get full text
Journal Article -
3
Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys
Published in PloS one (08-01-2014)“…The Block 2 region of the merozoite surface protein-1 (MSP-1) of Plasmodium falciparum has been identified as a target of protective immunity by a combination…”
Get full text
Journal Article -
4
In Human Autoimmunity, a Substantial Component of the B Cell Repertoire Consists of Polyclonal, Barely Mutated IgG +ve B Cells
Published in Frontiers in immunology (20-03-2020)“…B cells are critical for promoting autoimmunity and the success of B cell depletion therapy in rheumatoid arthritis (RA) confirms their importance in driving…”
Get full text
Journal Article -
5
A Conserved TCRβ Signature Dominates a Highly Polyclonal T-Cell Expansion During the Acute Phase of a Murine Malaria Infection
Published in Frontiers in immunology (23-11-2020)“…CD4 αβ T-cells are key mediators of the immune response to a first infection, undergoing extensive activation and splenic expansion during the acute phase of…”
Get full text
Journal Article -
6
Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis
Published in Vaccine (10-10-2007)“…Abstract Anthrolysin O (ALO) is a toxin produced by Bacillus anthracis , the causative agent of anthrax. It is a member of the cholesterol-dependent cytolysin…”
Get full text
Journal Article -
7
AIRRSHIP: simulating human B cell receptor repertoire sequences
Published in Bioinformatics (Oxford, England) (01-06-2023)“…Abstract Summary Adaptive Immune Receptor Repertoire Sequencing is a rapidly developing field that has advanced understanding of the role of the adaptive…”
Get full text
Journal Article -
8
Presence of Nonhemolytic Pneumolysin in Serotypes of Streptococcus pneumoniae Associated with Disease Outbreaks
Published in The Journal of infectious diseases (15-09-2007)“…Pneumolysin is an important virulence factor of the human pathogen Streptococcus pneumoniae. Sequence analysis of the ply gene from 121 clinical isolates of S…”
Get full text
Journal Article -
9
Abnormal proliferation and spontaneous differentiation of myoblasts from a symptomatic female carrier of X-linked Emery–Dreifuss muscular dystrophy
Published in Neuromuscular disorders : NMD (01-02-2015)“…Highlights • X-linked female presenting with EDMD1 not explained by uneven X-inactivation. • First EDMD blood phenotype with highly lobulated lymphocytes in…”
Get full text
Journal Article -
10
Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59
Published in Molecular immunology (01-04-2009)“…The unique species specificity of the bacterial cytolysin intermedilysin is explained by its requirement for the human complement regulator CD59 as the primary…”
Get full text
Journal Article -
11
-
12
Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not againstBacillus anthracis
Published in Vaccine (10-10-2007)“…Anthrolysin O (ALO) is a toxin produced byBacillus anthracis, the causative agent of anthrax. It is a member of the cholesterol-dependent cytolysin (CDC) group…”
Get full text
Journal Article -
13
A Novel Malaria Vaccine Candidate Antigen Expressed in Tetrahymena thermophila: e87198
Published in PloS one (01-01-2014)“…Development of effective malaria vaccines is hampered by the problem of producing correctly folded Plasmodium proteins for use as vaccine components. We have…”
Get full text
Journal Article -
14
Antibody Responses to a Novel Plasmodium falciparum Merozoite Surface Protein Vaccine Correlate with Protection against Experimental Malaria Infection in Aotus Monkeys: e83704
Published in PloS one (01-01-2014)“…The Block 2 region of the merozoite surface protein-1 (MSP-1) of Plasmodium falciparum has been identified as a target of protective immunity by a combination…”
Get full text
Journal Article -
15